Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dave Singh

Showing results (351-360 of 505) with videos related to

Pageof 51
Sort By:
Lancet (London, England)|February 13, 2018
Extrafine inhaled triple therapy versus dual bronchodilator therapy in chronic obstructive pulmonary disease (TRIBUTE): a double-blind, parallel group, randomised controlled trialAlberto Papi, Jørgen Vestbo, Leonardo Fabbri, et al.
Expert Review of Vaccines|September 11, 2023
A review of evidence for pneumococcal vaccination in adults at increased risk of pneumococcal disease: risk group definitions and optimization of vaccination coverage in the United KingdomJames Campling, Andrew Vyse, Hui-Hsuan Liu, et al.
Lancet (London, England)|October 5, 2019
Single inhaler extrafine triple therapy in uncontrolled asthma (TRIMARAN and TRIGGER): two double-blind, parallel-group, randomised, controlled phase 3 trialsJohann Christian Virchow, Piotr Kuna, Pierluigi Paggiaro, et al.
BMC Pulmonary Medicine|February 22, 2017
Characteristics and longitudinal progression of chronic obstructive pulmonary disease in GOLD B patientsPhilip J Lawrence, Umme Kolsum, Vandana Gupta, et al.
The Journal of Allergy and Clinical Immunology. in Practice|August 24, 2025
Detecting small airways dysfunction in asthma: Rationale, findings, and future of ATLANTISSalman Siddiqui, Christopher Brightling, Dave Singh, et al.
Pulmonary Pharmacology & Therapeutics|September 8, 2015
The role of CRAC channel in asthmaManminder Kaur, Mark A Birrell, Bilel Dekkak, et al.
Radiology|January 10, 2015
MR Quantitative Equilibrium Signal Mapping: A Reliable Alternative to CT in the Assessment of Emphysema in Patients with Chronic Obstructive Pulmonary DiseaseWei-Juan Zhang, Penny L Hubbard Cristinacce, Eva Bondesson, et al.
British Journal of Clinical Pharmacology|August 30, 2025
AZD0449, an inhaled JAK1 inhibitor, in healthy participants and patients with mild asthmaAnna Lundahl, Rod Hughes, Joachim Almquist, et al.
Life (Basel, Switzerland)|December 18, 2020
Outcomes Evaluated in Controlled Clinical Trials on the Management of COVID-19: A Methodological Systematic ReviewAlexander G Mathioudakis, Markus Fally, Rola Hashad, et al.
Advances in Therapy|November 11, 2020
Tiotropium/Olodaterol Delays Clinically Important Deterioration Compared with Tiotropium Monotherapy in Patients with Early COPD: a Post Hoc Analysis of the TONADO<sup>®</sup> TrialsKlaus F Rabe, James D Chalmers, Marc Miravitlles, et al.
Pageof 51

Showing results (351-360 of 505) with videos related to

Sort By:
Pageof 51
Lancet (London, England)|February 13, 2018
Extrafine inhaled triple therapy versus dual bronchodilator therapy in chronic obstructive pulmonary disease (TRIBUTE): a double-blind, parallel group, randomised controlled trialAlberto Papi, Jørgen Vestbo, Leonardo Fabbri, et al.
Expert Review of Vaccines|September 11, 2023
A review of evidence for pneumococcal vaccination in adults at increased risk of pneumococcal disease: risk group definitions and optimization of vaccination coverage in the United KingdomJames Campling, Andrew Vyse, Hui-Hsuan Liu, et al.
Lancet (London, England)|October 5, 2019
Single inhaler extrafine triple therapy in uncontrolled asthma (TRIMARAN and TRIGGER): two double-blind, parallel-group, randomised, controlled phase 3 trialsJohann Christian Virchow, Piotr Kuna, Pierluigi Paggiaro, et al.
BMC Pulmonary Medicine|February 22, 2017
Characteristics and longitudinal progression of chronic obstructive pulmonary disease in GOLD B patientsPhilip J Lawrence, Umme Kolsum, Vandana Gupta, et al.
The Journal of Allergy and Clinical Immunology. in Practice|August 24, 2025
Detecting small airways dysfunction in asthma: Rationale, findings, and future of ATLANTISSalman Siddiqui, Christopher Brightling, Dave Singh, et al.
Pulmonary Pharmacology & Therapeutics|September 8, 2015
The role of CRAC channel in asthmaManminder Kaur, Mark A Birrell, Bilel Dekkak, et al.
Radiology|January 10, 2015
MR Quantitative Equilibrium Signal Mapping: A Reliable Alternative to CT in the Assessment of Emphysema in Patients with Chronic Obstructive Pulmonary DiseaseWei-Juan Zhang, Penny L Hubbard Cristinacce, Eva Bondesson, et al.
British Journal of Clinical Pharmacology|August 30, 2025
AZD0449, an inhaled JAK1 inhibitor, in healthy participants and patients with mild asthmaAnna Lundahl, Rod Hughes, Joachim Almquist, et al.
Life (Basel, Switzerland)|December 18, 2020
Outcomes Evaluated in Controlled Clinical Trials on the Management of COVID-19: A Methodological Systematic ReviewAlexander G Mathioudakis, Markus Fally, Rola Hashad, et al.
Advances in Therapy|November 11, 2020
Tiotropium/Olodaterol Delays Clinically Important Deterioration Compared with Tiotropium Monotherapy in Patients with Early COPD: a Post Hoc Analysis of the TONADO<sup>®</sup> TrialsKlaus F Rabe, James D Chalmers, Marc Miravitlles, et al.
Pageof 51